(Q39588900)

13 September 2017

α-Synuclein increases U251 cells vulnerability to hydrogen peroxide by disrupting calcium homeostasis (English)

1 reference

13 September 2017

1 reference

Zhengxin Ying

1

1 reference

13 September 2017

Fankai Lin

2

1 reference

13 September 2017

Weihong Gu

3

1 reference

13 September 2017

Yang Su

4

1 reference

13 September 2017

Abida Arshad

5

1 reference

13 September 2017

Hong Qing

6

1 reference

13 September 2017

Yulin Deng

7

1 reference

13 September 2017

20 February 2011

1 reference

Journal of Neural Transmission

13 September 2017

1 reference

13 September 2017

118

1 reference

13 September 2017

8

1 reference

13 September 2017

1165-1172

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-011-0596-7

13 September 2017

0 references

cites work

Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Different species of alpha-synuclein oligomers induce calcium influx and seeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Free radicals in the physiological control of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Neural activity controls the synaptic accumulation of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Synucleinopathies: clinical and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Linking calcium to Abeta and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Identification of two distinct synucleins from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Calcium and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Regulation of cell death: the calcium-apoptosis link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Subcellular localisation of recombinant alpha- and gamma-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Glial cell death induced by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

In vitro models of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Calcium, ageing, and neuronal vulnerability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

The role of alpha-synuclein in the pathogenesis of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Multiple system atrophy: a primary oligodendrogliopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0596-7

Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21336954

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21336954

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Improving the survival of grafted dopaminergic neurons: a review over current approaches.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21336954

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00702-011-0596-7

1 reference

13 September 2017

1 reference